AC Immune S.A. (ACIU)
NASDAQ·Healthcare·Biotechnology
$2.24
-3.03%
Mkt Cap $287.72M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+271.9%
Consensus $8.33 vs current $2.24
NASDAQ·Healthcare·Biotechnology
$2.24
-3.03%
Mkt Cap $287.72M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+271.9%
Consensus $8.33 vs current $2.24